FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit

News January 7, 2025

STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests